The contribution of single-cell analysis of acute leukemia in the therapeutic strategy

After decades during which the treatment of acute myeloblastic leukemia was limited to variations around a skeleton of cytarabine/anthracycline, targeted therapies appeared. These therapies, first based on monoclonal antibodies, also rely on specific inhibitors of various molecular abnormalities. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Madaci, Lamia, Colle, Julien, Venton, Geoffroy, Farnault, Laure, Loriod, Béatrice, Costello, Régis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237443/
https://www.ncbi.nlm.nih.gov/pubmed/34176517
http://dx.doi.org/10.1186/s40364-021-00300-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237443/
https://www.ncbi.nlm.nih.gov/pubmed/34176517
http://dx.doi.org/10.1186/s40364-021-00300-0

Ejemplares similares